SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-18-004853
Filing Date
2018-07-02
Accepted
2018-07-02 17:27:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2236164zs-3.htm S-3 266177
2 EX-1.2 a2236164zex-1_2.htm EX-1.2 245708
3 EX-5.1 a2236164zex-5_1.htm EX-5.1 20265
4 EX-5.2 a2236164zex-5_2.htm EX-5.2 8127
5 EX-23.1 a2236164zex-23_1.htm EX-23.1 3239
6 G621404.JPG g621404.jpg GRAPHIC 32960
7 G162952KII001.JPG g162952kii001.jpg GRAPHIC 2154
  Complete submission text file 0001047469-18-004853.txt   593198
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226055 | Film No.: 18934046
SIC: 2834 Pharmaceutical Preparations